CNTN
Canton Strategic Holdings, Inc.
NASDAQ: CNTN · HEALTHCARE · BIOTECHNOLOGY
$1.93
-5.39% today
Updated 2026-07-29
Market cap
$157.33M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.36
Dividend yield
—
52W range
$1 – $9
Volume
1.0M
WallStSmart proprietary scores
27
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.3
Quality
B3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.54 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-62.46M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-8.47M | $-9.32M | $-12.20M | $-35.92M | $-47.34M |
| EPS | — | — | — | — | $-0.36 |
| Free cash flow | $-6.56M | $-7.30M | $-10.90M | $-93.70M | $-62.46M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Canton Strategic Holdings, Inc. trades at $1.93. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.54, it sits in the distress.
Frequently asked questions
What is Canton Strategic Holdings, Inc.'s stock price?
Canton Strategic Holdings, Inc. (CNTN) trades at $1.93.
Is Canton Strategic Holdings, Inc. overvalued?
Canton Strategic Holdings, Inc. carries a Smart Value Score of 27/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Canton Strategic Holdings, Inc.'s Altman Z-Score is 1.54, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-34.40%
Beta1.44
50D MA$2.75
200D MA$3.22
Shares out0.08B
Float0.06B
Short ratio—
Avg volume1.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—